Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 12.39% is 915% above its 5-year average of -1.52%, near the high end of its 5-year range (-51.17%–24.65%).
2.25% above its 12-month average of 12.12%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 3.23%.
NET PROFIT MARGIN
12.39%
NET PROFIT MARGIN AVG TTM
12.12%
NET PROFIT MARGIN AVG 3Y
7.06%
NET PROFIT MARGIN AVG 5Y
-1.52%
NET PROFIT MARGIN AVG 10Y
-31.38%
NET PROFIT MARGIN AVG 15Y
-35.90%
NET PROFIT MARGIN AVG 20Y
-33.09%
CURRENT VS TTM AVG
+2.25%
CURRENT VS 3Y AVG
+75.58%
CURRENT VS 5Y AVG
+914.96%
CURRENT VS 10Y AVG
+139.49%
CURRENT VS 15Y AVG
+134.51%
CURRENT VS 20Y AVG
+137.44%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 758 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Niagen Bioscience Inc
Market Cap
$214.39M
Net Profit Margin
12.39%
TTM Avg
12.12%
3Y Avg
7.06%
5Y Avg
-1.52%
Market Cap
$214.35M
Net Profit Margin
-269.75%
TTM Avg
-1318.17%
3Y Avg
-659.09%
5Y Avg
-439.39%
Market Cap
$216.72M
Net Profit Margin
-850.13%
TTM Avg
-398.77%
3Y Avg
-257.91%
5Y Avg
-325.14%
Market Cap
$211.33M
Net Profit Margin
47.55%
TTM Avg
-1.25%
3Y Avg
-126.95%
5Y Avg
-427.13%
Market Cap
$218.09M
Net Profit Margin
-920285.19%
TTM Avg
-662320.41%
3Y Avg
-376335.80%
5Y Avg
-251721.50%
Market Cap
$218.36M
Net Profit Margin
74.06%
TTM Avg
51.52%
3Y Avg
44.79%
5Y Avg
47.28%
Market Cap
$209.27M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$208.90M
Net Profit Margin
-10422.48%
TTM Avg
-2428.80%
3Y Avg
-1417.64%
5Y Avg
-1019.29%
Market Cap
$221.27M
Net Profit Margin
-553.88%
TTM Avg
-2620.95%
3Y Avg
-26640.28%
5Y Avg
-17808.90%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Niagen Bioscience Inc (NAGE) | $214.39M | 12.39% | 12.12% | 7.06% | -1.52% |
| Prelude Therapeutics Incorporated (PRLD)vs › | $214.35M | -269.75% | -1318.17% | -659.09% | -439.39% |
| Alector, Inc. (ALEC)vs › | $216.72M | -850.13% | -398.77% | -257.91% | -325.14% |
| Compugen Ltd. (CGEN)vs › | $211.33M | 47.55% | -1.25% | -126.95% | -427.13% |
| Lyell Immunopharma, Inc. (LYEL)vs › | $218.09M | -920285.19% | -662320.41% | -376335.80% | -251721.50% |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $218.36M | 74.06% | 51.52% | 44.79% | 47.28% |
| Sionna Therapeutics, Inc. (SION)vs › | $209.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $208.90M | -10422.48% | -2428.80% | -1417.64% | -1019.29% |
| Keros Therapeutics, Inc. (KROS)vs › | $221.27M | -553.88% | -2620.95% | -26640.28% | -17808.90% |
| Pro-Dex, Inc. (PDEX)vs › | $206.63M | 17.62% | 15.55% | 12.60% | 12.03% |
Operating Margin
6.7%
Net Profit Margin
12.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 3.23% |
| 2026-03-31 | 20.07% |
| 2025-12-31 | 12.21% |
| 2025-09-30 | 13.47% |
| 2025-06-30 | 11.60% |
| 2025-03-31 | 16.61% |
| 2024-12-31 | 24.65% |
| 2024-09-30 | 7.34% |
| 2024-06-30 | -0.07% |
| 2024-03-31 | -2.22% |
| 2023-12-31 | 0.54% |
| 2023-09-30 | -4.92% |
| 2023-06-30 | -10.78% |
| 2023-03-31 | -8.43% |
| 2022-12-31 | -6.75% |
| 2022-09-30 | -5.77% |
| 2022-06-30 | -38.23% |
| 2022-03-31 | -44.85% |
| 2021-12-31 | -29.98% |
| 2021-09-30 | -51.17% |
| 2021-06-30 | -31.45% |
| 2021-03-31 | -50.27% |
| 2020-12-31 | -39.48% |
| 2020-09-30 | -29.72% |
| 2020-06-30 | -24.28% |
| 2020-03-31 | -41.14% |
| 2019-12-31 | -67.64% |
| 2019-09-30 | -59.75% |
| 2019-06-30 | -69.86% |
| 2019-03-31 | -82.97% |
| 2018-12-31 | -90.64% |
| 2018-09-30 | -105.97% |
| 2018-06-30 | -103.17% |
| 2018-03-31 | -128.57% |
| 2017-12-31 | -117.14% |
| 2017-09-30 | 35.12% |
| 2017-06-30 | -65.53% |
| 2017-03-31 | -57.27% |
| 2016-12-31 | -38.05% |
| 2016-09-30 | -24.24% |
| 2016-06-30 | -0.94% |
| 2016-03-31 | 3.49% |
| 2015-12-31 | -32.69% |
| 2015-09-30 | -0.06% |
| 2015-06-30 | -5.17% |
| 2015-03-31 | -19.49% |
| 2014-12-31 | -28.93% |
| 2014-09-30 | -15.93% |
| 2014-06-30 | -42.87% |
| 2014-03-31 | -60.11% |
| 2013-12-31 | -30.16% |
| 2013-09-30 | -46.00% |
| 2013-06-30 | -37.71% |
| 2013-03-31 | -61.00% |
| 2012-12-31 | -48.22% |
| 2012-09-30 | -42.34% |
| 2012-06-30 | -149.55% |
| 2012-03-31 | -248.28% |
| 2011-12-31 | -137.80% |
| 2011-09-30 | -131.59% |
| 2011-06-30 | -95.08% |
| 2011-03-31 | -45.54% |
| 2010-12-31 | -44.21% |
| 2010-09-30 | -56.53% |
| 2010-06-30 | -14.92% |
| 2010-03-31 | 1.74% |
| 2009-12-31 | -7.40% |
| 2009-09-30 | -12.39% |
| 2009-06-30 | -21.68% |
| 2009-03-31 | -22.38% |
| 2008-12-31 | -55.11% |
| 2008-09-30 | -66.45% |
| 2008-06-30 | -51.85% |
| 2008-02-29 | 0.00% |
| 2007-11-30 | 0.00% |
| 2007-08-31 | 0.00% |
| 2007-05-31 | 0.00% |
| 2007-02-28 | 0.00% |
